Med. Pro Praxi 2008; 5(2): 54-58

diagnostika a léčba venózní tromboembolické nemoci

MUDr. Bohdan Kadlec, doc. MUDr. Jana Skřičková CSc
Klinika nemocí plicních a tuberkulózy, FN Brno Bohunice

Venózní tromboembolická nemoc patří mezi běžná onemocnění, postihující 7 z 10 000 obyvatel každoročně. Je významnou příčinou morbidity a mortality, a to zejména u starších lidí. Terapie se řídí závažností onemocnění a zahrnuje léčbu antikoagulační a antitrombotickou, trombolytickou, léčbu intervenční a chirurgickou.

Keywords: venózní tromboembolická nemoc, plicní embolie, hluboká žilní trombóza

Published: May 21, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kadlec B, Skřičková J. diagnostika a léčba venózní tromboembolické nemoci. Med. praxi. 2008;5(2):54-58.
Download citation

References

  1. ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Thrombembolism in pregnancy. Int J Gynaecol Obstet. 2001; 75: 203-212. Go to original source... Go to PubMed...
  2. Aujesky D, Obrosky DS, Stone RA et al. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med. 2006; 166: 169-175. Go to original source... Go to PubMed...
  3. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER), Lancet 1999; 353: 1386-1389. Go to original source... Go to PubMed...
  4. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000; 160: 769-774. Go to original source... Go to PubMed...
  5. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000; 160: 761-768. Go to original source... Go to PubMed...
  6. Huse DM, Cummins G, Taylor DC, Russell MW. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Am J Manag Care. 2002; 8: S10-S16. Go to PubMed...
  7. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004; 141: 249-256. Go to original source... Go to PubMed...
  8. Qaseem A, Snow V, Barry P et al. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Fam Med. 2007; 5(1): 57-62. Go to original source... Go to PubMed...
  9. Rocha E, Martínez-González MA, Montes R, Panizo C. Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis. Haematologica. 2000; 85: 935-942. Go to PubMed...
  10. Rodger MA, Gagné-Rodger C, Howley HE, Carrier M, Coyle D, Wells PS. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy. Thromb Res. 2003; 112: 13-18. Go to original source... Go to PubMed...
  11. Rymes NL, Lester W, Connor C, Chakrabarti S, Fegan CD. Outpatient management of DVT using low molecular weight heparin and a hospital outreach service. Clin Lab Haematol. 2002; 24: 165-170. Go to original source... Go to PubMed...
  12. Segal JB, Eng J, Jenckes MW et al. Diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Evid Rep Technol Assess (Summ). 2003: 1-6.
  13. Segal JB, Streiff MB, Hoffman LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007; 146(3): 211-222. Go to original source... Go to PubMed...
  14. Widimský J, Malý J. Doporučení pro diagnostiku a léčbu plicní embolie. Verze 2001. Cor Vasa 2001; 43: K158-K184.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.